pocketful logo
Pfizer Ltd logo

Pfizer Ltd

NSE: PFIZER BSE: 500680

4704.50

(-2.06%)

Thu, 12 Mar 2026, 08:26 am

Pfizer Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    21519.73

  • Net Profit

    767.60

  • P/B

    4.34

  • Sector P/E

    40.99

  • P/E

    23.86

  • EV/EBITDA

    14.33

  • Debt/Equity (Industry)

    0.09

  • Interest Cover (Industry)

    38.34

  • ROCE (Industry)

    22.21

  • RONW (Industry)

    17.92

  • ROE

    19.78

  • ROCE

    27.27

  • Debt/Equity

    0

  • EPS (TTM)

    166.47

  • Dividend Yield

    3.51

  • Book Value

    841.20

  • Interest Cover

    0

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (4.9x coverage).
  • Pfizer is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Pfizer is profitable, therefore cash runway is not a concern.
  • Pfizer is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Pfizer's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Pfizer's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Pfizer is not covered by any analysts.
  • Pfizer's 1-year earnings growth is less than its 5-year average (18.6% vs 25.2%)

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters63.9263.9263.9263.9263.92
FII2.712.602.392.182.75
DII17.0517.1017.2317.1016.79
Public16.3216.3716.4516.8016.54
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

41.57

MACD

-31.51

50 DMA

4841.51

200 DMA

5175.18

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic6520.405723.405392.804926.404595.804129.403332.40
Fibonacci5723.405418.955230.854926.404621.954433.854129.40
Camarilla5281.385208.325135.264926.404989.144916.084843.02

Pivots Level: Classic

R3

+1594

6520.40

R2

+797

5723.40

R1

+466.40

5392.80

4926.40
4926.40
Pivot Point
LTP: 4725

S1

-330.60

4595.80

S2

-797

4129.40

S3

-1594

3332.40

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    4832.19

  • 20-EMA

    4874.67

  • 30-EMA

    4880.89

  • 50-EMA

    4893.74

  • 100-EMA

    4946.98

  • 200-EMA

    4986.43

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
09 Feb 2026board-meetingsQuarterly Results, Nine Months Results
09 Jun 2025dividendSpecial Dividend - Rs. - 13009 Jul 2025
19 May 2025dividend₹35.00 Dividend /Share09 Jul 2025
19 May 2025agm
09 Aug 2024agm
21 Jul 2024dividendFinal Dividend - Rs. - 3521 Aug 2024
17 May 2024dividend₹35.00 Dividend /Share21 Aug 2024
27 Jul 2023agm
11 Jul 2023dividendFinal Dividend - Rs. - 3511 Aug 2023
15 May 2023dividend₹35.00 Dividend /Share11 Aug 2023

Read More

Peer Comparison

Pfizer Ltd logo

Pfizer Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Pfizer Ltd About

Pfizer is engaged in manufacturing, marketing, distribution and trading of pharmaceutical products.

Industry

Pharmaceuticals - Multinational

Founded

1950

Headquarters

CEO

Pradip P Shah

Employees

Contact

Website icon

Website

http://www.pfizerindia.com

Email icon

Email

contactus.india@pfizer.com

Phone icon

Phone

91-22-66932000

Location icon

Location

The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E, Mumbai, Maharashtra, 400051

Read More

Pfizer Ltd Company History

YearHistory
2017
  • Acquired AstraZeneca’s Neksium for INR 750 million.
2018
  • Entered ICMR partnership on Antimicrobial Resistance.
2021
  • Pfizer and BioNTech finalized agreement to supply 200 million COVID-19 vaccine doses to EU.
2022
  • Launched ‘Pfizer PAP India’ assistance app.
  • Launched Project Aastha Cancer-Care Services and Helpdesk at Sawai Man Singh Hospital, Jaipur.
  • Partnered with Father Muller Research to strengthen evidence generation.
  • Partnered with Max Super Speciality Hospitals.
  • Set up global drug development center in India.
2023
  • Entered into agreement to assign lease of MIDC land and sell building.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
No Result Found

Read More

Pfizer Ltd News

5 Stocks Trading Below 5-Year Average PE Ratios

IRB Infrastructure, Pfizer, Jyoti CNC, HBL Engineering, and Anant Raj are trading at P/E ratios 28-61 versus their 5-year averages of 32-84, suggesting potential undervaluation opportunities.

25 Jan 2026

stocks

Pfizer Limited Announces Senior Management Changes

Pfizer Limited announces key senior management changes effective February 1, 2026, including appointment of Nilesh Pendse as Category Lead – Vaccines and organizational restructuring across business divisions.

20 Jan 2026

stocks

Pfizer Faces ₹8.79 Cr GST Demand from West Bengal

Pfizer Limited receives significantly higher GST demand order of ₹8.79 crores from West Bengal authorities for FY2018-23, plans to appeal against the order citing it as non-maintainable.

24 Dec 2025

stocks

Pfizer Limited Senior Management Personnel Change

Ms. Aditi Mehta, Category Lead-Vaccines at Pfizer Limited, has resigned from her position effective January 2, 2026, to pursue opportunities outside the company.

23 Dec 2025

stocks

Pfizer Ltd Shares Worth Rs 100.37 Crores Traded in NSE Block Deal

Pfizer Ltd witnessed a block trade on NSE involving 200,949 shares at Rs 4,995 per share, totaling Rs 100.37 crores. The transaction represents a significant institutional or bulk investor activity in the pharmaceutical company's stock.

25 Nov 2025

order&deals

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800